美国 · SEC FORM 4
Galecto, Inc.
GLTO · Nasdaq · CIK 0001800315 · Healthcare
内部人信号
1 qualifying P purchase group
当前 180 天评分窗口
3 同一窗口内观察到的 Form 4 交易行
1 sales · 1 期权、代扣税、授予、赠与或其他交易行
为什么没有活跃信号？
评分构成
活跃窗口内没有合资格买入，因此不计算分数。缺失的输入不会被当作零分或看空信号。
为什么没有分数？
- 没有合资格公开市场买入可提供聚集度、规模、角色、近期性或确信度输入。
- 卖出及其他 Form 4 活动继续作为背景显示，不会形成负分。
卖出和其他 Form 4 活动会单独显示，不会形成负面买入信号。没有买入不会被评分为看空。
内部人活动时间轴
申报人轨道展示最近 180 天。符号形状区分交易类型；卖出仅作为背景。
—
买方广度与集中度
Roles in the peak window: Director, President and CEO. Concentration uses priced qualifying P lines only and does not change the saved score.
信号历史
Scores are archived only when the company qualifies for a published US buy-signal snapshot. 最近一次合资格买入: 2026-09-25 · Jarrett Jennifer.
近期 Form 4 活动
P is an open-market or private purchase. S is a sale. M, F, A and G usually describe exercises, tax withholding, awards and gifts. These categories remain visually separate.
市场背景
该股票尚未获取市场背景。每日任务会轮转处理美国股票池。
空头余额
FINRA 报告中没有该股票代码的空头余额。
FINRA 结算日：2026-09-30 · 获取日期 2026-10-12 · FINRA 股票空头余额 ↗. 这是股数，每月两个结算日之后约一周公布；不是占已发行股份的比例。
历史股票买入
Qualifying code P transactions in the local Form 4 history, including purchases outside the current signal window.
| Transaction date | Reporting owner | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-09-25 | Jarrett Jennifer | 买入 (P) | Ordinary Shares | 12,500 | USD 20.23 | USD 252,875 | SEC 申报 ↗ |
| 2022-03-22 | Schambye Hans T. | 买入 (P) | Common Stock | 5,000 | USD 2.15 | USD 10,750 | SEC 申报 ↗ |
| 2022-03-22 | Lindmark Bertil | 买入 (P) | Common Stock | 14,604 | USD 2.16 | USD 31,545 | SEC 申报 ↗ |
| 2021-12-03 | Winslow Garrett | 买入 (P) | Common Stock | 2,000 | USD 2.48 | USD 4,960 | SEC 申报 ↗ |
| 2021-12-03 | Freve Jonathan | 买入 (P) | Common Stock | 4,000 | USD 2.49 | USD 9,960 | SEC 申报 ↗ |
| 2021-11-09 | Schambye Hans T. | 买入 (P) | Common Stock | 4,500 | USD 3.50 | USD 15,750 | SEC 申报 ↗ |
| 2021-11-08 | Freve Jonathan | 买入 (P) | Common Stock | 3,000 | USD 3.40 | USD 10,200 | SEC 申报 ↗ |
| 2021-08-18 | Freve Jonathan | 买入 (P) | Common Stock | 3,000 | USD 3.92 | USD 11,760 | SEC 申报 ↗ |
| 2021-06-28 | Lindmark Bertil | 买入 (P) | Common Stock | 2,000 | USD 5.26 | USD 10,520 | SEC 申报 ↗ |
| 2021-06-24 | Schambye Hans T. | 买入 (P) | Common Stock | 3,000 | USD 5.11 | USD 15,330 | SEC 申报 ↗ |
| 2021-06-23 | Winslow Garrett | 买入 (P) | Common Stock | 2,000 | USD 4.80 | USD 9,600 | SEC 申报 ↗ |
| 2021-06-23 | Freve Jonathan | 买入 (P) | Common Stock | 2,000 | USD 4.74 | USD 9,480 | SEC 申报 ↗ |
| 2020-11-02 | ORBIMED ADVISORS LLC; OrbiMed Advisors Israel II Ltd; OrbiMed Capital GP VII LLC; OrbiMed Genesis GP LLC; OrbiMed Israel GP II, L.P. | 买入 (P) | Common Shares | 733,333 | USD 15.00 | USD 10,999,995 | SEC 申报 ↗ |
| 2020-11-02 | Novo Holdings A/S | 买入 (P) | COMMON STOCK | 333,333 | USD 15.00 | USD 4,999,995 | SEC 申报 ↗ |
| 2020-11-02 | Khuong Chau Quang | 买入 (P) | Common Shares | 733,333 | USD 15.00 | USD 10,999,995 | SEC 申报 ↗ |
Form 4 申报证据
14 transaction lines in the latest 365-day window; 93 in local history.
| 日期 | 申报人 | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-09-25 | Jarrett Jennifer | 买入 (P) | Ordinary Shares | 12,500 | USD 20.23 | USD 252,875 | SEC 申报 ↗ |
| 2026-07-06 | Winslow Garrett | 卖出 (S) | Common Stock | 245 | USD 29.98 | USD 7,345 | SEC 申报 ↗ |
| 2026-07-03 | Winslow Garrett | 期权行权／转换 (M) | Common Stock | 680 | USD — | USD — | SEC 申报 ↗ |
展开近期 Form 4 证据 (13 grouped rows)
| 日期 | 申报人 | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-09-25 | Jarrett Jennifer | 买入 (P) | Ordinary Shares | 12,500 | USD 20.23 | USD 252,875 | SEC 申报 ↗ |
| 2026-07-06 | Winslow Garrett | 卖出 (S) | Common Stock | 245 | USD 29.98 | USD 7,345 | SEC 申报 ↗ |
| 2026-07-03 | Winslow Garrett | 期权行权／转换 (M) | Common Stock | 680 | USD — | USD — | SEC 申报 ↗ |
| 2026-02-09 | Fairmount Funds Management LLC; Fairmount Healthcare Co-Invest V L.P.; Fairmount Healthcare Fund II L.P.; Harwin Peter Evan; Kiselak Tomas | 期权行权／转换 (M) | Common Stock | 8,713,000 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-02-09 | Bruno Julianne | 期权行权／转换 (M) | Common Stock | 129,000 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-01-05 | Sattarzadeh Sherwin | 奖励／授予 (A) | Common Stock | 190,376 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-01-05 | Hewes L. Becker | 奖励／授予 (A) | Common Stock | 264,629 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-01-02 | Winslow Garrett | 卖出 (S) | Common Stock | 255 | USD 21.38 | USD 5,452 | SEC 申报 ↗ |
| 2026-01-02 | Winslow Garrett | 期权行权／转换 (M) | Common Stock | 680 | USD — | USD — | SEC 申报 ↗ |
| 2026-01-02 | Schambye Hans T. | 卖出 (S) | Common Stock | 700 | USD 21.38 | USD 14,966 | SEC 申报 ↗ |
| 2026-01-02 | Schambye Hans T. | 期权行权／转换 (M) | Common Stock | 1,360 | USD — | USD — | SEC 申报 ↗ |
| 2026-01-02 | Firmani Lori | 卖出 (S) | Common Stock | 135 | USD 21.41 | USD 2,890 | SEC 申报 ↗ |
| 2026-01-02 | Firmani Lori | 期权行权／转换 (M) | Common Stock | 374 | USD — | USD — | SEC 申报 ↗ |
Multiple price lines in one filing are grouped and share-weighted. Price and value are blank when a grouped filing line lacks price evidence.
快照与身份
| 快照日期 | 2026-10-18 |
|---|---|
| 排名版本 | US-v1.2 |
| 数据质量 | PASS ELIGIBLE · — |
| 股票代码 | GLTO |
| CIK | 0001800315 |
| 行业 | Healthcare |
| 细分行业 | — Yahoo Finance |
| SEC SIC | 2834 Pharmaceutical Preparations |
| 交易所 | Nasdaq |
数据覆盖
| 本地 Form 4 历史 | 93 transaction lines from 2020-11-02 to 2026-09-25 18 P purchase lines · 46 S sale lines · 29 other lines |
|---|---|
| SEC 公司申报 | 打开 SEC 申报 ↗ |
Local ledger as of 2026-10-18. Mapping status is an audit field and does not erase SEC filing evidence.